News and Articles on Ayurveda, Yoga, Kundalini and other Indian way of health and medicines.
Surging ahead with a dramatic growth in sales of its products, Indian Medicines Pharmaceutical Corporation Limited (IMPCL), the public sector manufacturing unit of the Ministry of AYUSH has recorded a turnover of Rs 164.33 Crore (tentative figure) for the financial year 2020-21.
India has scaled another peak in its effort to contain the COVID-19 virus with the administration of more than 100 million (10 Cr) vaccines to its citizens. The cumulative number of COVID19 vaccine doses administered in the country stands at 10,12,84,282 as per the provisional report 08:00 pm on Saturday.
A Memorandum of Understanding betweenDepartment of Animal Husbandry and Dairying (DAHD), Ministry of Fisheries, Animal Husbandry and Dairying, Government of India and Ministry of AYUSH, Government of India was signed on 7th April, 2021 to introduce the concept of Ayurveda and its allied disciplines into veterinary science by their promotion in research and development including research on new formulations in quality drugs for veterinary science through medicinal herbs.
The Union Health Ministry announced on Wednesday that India has become the world’s fastest COVID-19 vaccine vaccinating country, with a daily average of 30,93,861 vaccine doses. India has now exceeded the US, which vaccinates 30.93 lakh people a day on average.
India and Japan on Tuesday signed four agreements under which Tokyo is to support health care projects funded under the Grant Assistance for Grassroots Projects (GGP) scheme in India.
India’s drug regulator has allowed the AstraZeneca Covid-19 vaccine to be used for up to nine months from its manufacture date, as opposed to the prescribed six months, according to a document reviewed by Reuters and a source.
“Indian Army has gifted one lakh doses of made in India COVID – 19 vaccines to Nepal Army and it will be helpful for the force,” sources from the Indian Embassy in Kathmandu said.
The Council of Scientific and Industrial Research and Bharat Biotech International are looking at bringing the messenger RNA platform to India after seeing its successful use in quick development of covid-19 vaccines by US-based Pfizer and Moderna.
India shipped out 200,000 doses of COVID-19 vaccines on Saturday to inoculate UN blue helmets serving in peacekeeping missions.
Researchers showed that the biochemical working of this drug molecule points to its promise in the treatment of COVID-19. The paper elaborates on the rationale of repurposing this drug for treating COVID-19 patients. Since the repurposed drug has gone through the clinical development process for the treatment of other diseases and has already been tested for toxicity, many steps in preclinical and early clinical development can be avoided and the drug can be directly tested on COVID-19 subjects in phase-II trials.
